CeriBell, Inc. (NASDAQ: CBLL) is capturing significant interest in the healthcare landscape, specifically within the medical devices sector. With a notable potential upside of 51.40%, as indicated by analyst ratings,..
Theravance Biopharma, Inc. (NASDAQ: TBPH), a prominent player in the biotechnology sector, is capturing the attention of investors with its promising pipeline and strategic partnerships. The company, headquartered in South..
Stoke Therapeutics, Inc. (NASDAQ: STOK) stands at the forefront of biotechnology innovation with a market cap of $1.99 billion. This Bedford, Massachusetts-based company is pioneering treatments for severe genetic diseases..
Zenas BioPharma, Inc. (ZBIO), a burgeoning name in the biotechnology sector, has caught the eye of investors with its potential upside of 89.53%. The company, headquartered in Waltham, Massachusetts, is..
Vir Biotechnology, Inc. (NASDAQ: VIR) is making headlines in the healthcare sector, particularly within the biotechnology industry. Headquartered in San Francisco, the company is at the forefront of developing therapeutic..
Bicara Therapeutics Inc. (NASDAQ: BCAX), a burgeoning player in the biotechnology sector, is capturing the attention of investors with its innovative approach to treating solid tumors. The Boston-based clinical-stage biopharmaceutical..
Cogent Biosciences, Inc. (NASDAQ: COGT), a clinical-stage biotechnology firm headquartered in Waltham, Massachusetts, is making waves with its innovative approach to precision therapies for genetically defined diseases. With a market..
Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a prominent player in the biotechnology sector, is capturing the attention of investors with a promising prospect of a 104.05% potential upside. As a..
For investors with a keen eye on the biotechnology sector, Kura Oncology, Inc. (NASDAQ: KURA) presents a compelling opportunity. This clinical-stage biopharmaceutical company, headquartered in San Diego, California, is on..
For investors scouting opportunities within the healthcare sector, Akso Health Group (NASDAQ: AHG) presents a unique case. Headquartered in Qingdao, China, this company operates in the medical distribution industry, a..
Fulgent Genetics, Inc. (NASDAQ: FLGT), a prominent player in the healthcare sector’s diagnostics and research industry, offers an intriguing proposition for investors seeking exposure to the healthcare diagnostics market. With..
For investors with a keen interest in the healthcare sector, Talkspace, Inc. (NASDAQ: TALK) presents an intriguing opportunity in the burgeoning field of virtual behavioral healthcare. With a market capitalization..
Castle Biosciences, Inc. (CSTL), a prominent player in the molecular diagnostics sector, is offering a promising prospect for investors, with an analyst consensus indicating a potential upside of 96.36%. Headquartered..
Capricor Therapeutics, Inc. (NASDAQ: CAPR), a clinical-stage biotechnology company based in San Diego, California, is making waves in the healthcare sector with its innovative approach to treating diseases with significant..
Community Health Systems, Inc. (NYSE: CYH) operates at the heart of the U.S. healthcare sector, providing a broad spectrum of medical services through its general acute care hospitals. Despite the..
Immatics N.V. (NASDAQ: IMTX), a pioneering force in the biotechnology sector, is capturing the attention of investors with its cutting-edge T cell redirecting immunotherapies aimed at revolutionizing cancer treatment. As..
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) is a key player in the biotechnology sector, focusing on the development of genetic therapies for rare and devastating diseases. The company’s innovative approach and..
Relay Therapeutics, Inc. (NASDAQ: RLAY), a clinical-stage biotechnology company, is making significant strides in the healthcare sector with its cutting-edge approach to drug discovery. With a market capitalization of $1.81..
Replimune Group, Inc. (NASDAQ: REPL), a clinical-stage biotechnology company, is making significant strides in the healthcare sector with its innovative approach to cancer treatment. Focused on developing and commercializing oncolytic..
